Gladstone Institutional Advisory’s Celgene Corp CELG Stock Holding History

Gladstone Institutional Advisory’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,379	Closed	-$237K	–	297
2019 Q3	$237K	Sell	2,379 -212	-8%	-$20.1K	0.06%	246
2019 Q2	$239K	Buy	2,591 +400	+18%	+$38K	0.07%	230
2019 Q1	$207K	Buy	+2,191	New	+$192K	0.08%	201

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Gladstone Institutional Advisory's CELG Position: Q4 2019 in Review

Gladstone Institutional Advisory sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,379 shares — an estimated $237K sold.

Gladstone Institutional Advisory first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $239K in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Gladstone Institutional Advisory reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Gladstone Institutional Advisory sold 2,379 Celgene Corp shares in Q4 2019, an estimated $237K.
Gladstone Institutional Advisory first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Gladstone Institutional Advisory's Celgene Corp position peaked at $239K in Q2 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2019, filed 12 Feb 2020.